Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00352391 · ClinicalTrials.gov registry record
Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 54
- Enrollment target
NCT00352391: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00352391 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00352391 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The goal of this research study is to look at how long individuals who have been treated for early stage NSCLC or HNSCC live without developing lung cancer. Another goal is to develop tools to help predict the likelihood of lung cancer occurrence in this population. This will be done by studying characteristics of tissue and bodily fluids (including blood). Objectives: * To assess the smoking-related disease-free survival in patients who are current or former smokers with a prior definitively-treated stage I/II lung or head and neck cancer. * To develop a risk model to help predict the likelihood of lung cancer development both imaging and biomarker based in this high-risk population.
Interventions
- OTHER Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2004-08 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00352391
The ClinicalTrials.gov registry entry for NCT00352391 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Assessments is the first listed.
NCT00352391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00352391 about?
NCT00352391 is a clinical study titled "Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients". The goal of this research study is to look at how long individuals who have been treated for early stage NSCLC or HNSCC live without developing lung cancer. Another goal is to develop tools to help predict the likelihood of lung cancer occurrence in this population. This will be done by studying cha...
What is the current status of trial NCT00352391?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2004-08. Estimated completion is 2016-01.
What interventions are being tested in trial NCT00352391?
The interventions under investigation include: Assessments (OTHER).
Who is sponsoring clinical trial NCT00352391?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.